[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
[ Tue, Mar 08th 2022 ]: WOPRAI
Joseph Schwartz Maintained (AUPH) at Buy with Decreased Target to $22 on, Mar 8th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Joseph Schwartz of SVB Leerink, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Decreased Target from $30 to $22 on, Mar 8th, 2022.
Joseph has made no other calls on AUPH in the last 4 months.
There are 2 other peers that have a rating on AUPH. Out of the 2 peers that are also analyzing AUPH, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Joseph
- Douglas Miehm of "RBC Capital" Maintained at Buy with Decreased Target to $27 on, Tuesday, March 1st, 2022
- Justin Kim of "Oppenheimer" Upgraded from Hold to Buy and Decreased Target to $31 on, Friday, December 10th, 2021